Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Filed Chapter 11
Director departure
Appointed director
Quarterly results
K-V Pharmaceutical Co (KV.A) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/05/2013 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
08/01/2013 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
07/24/2013 SC 13D Greywolf Capital Management LP reports a 7.3% stake in K-V Pharmaceutical Company
07/16/2013 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
07/12/2013 SC 13D DEUTSCHE BANK AG\ reports a 0% stake in K-V Pharmaceutical Company
06/06/2011 SC 13D KV PHARMACEUTICAL CO reports a 5.4% stake in K-V Pharmaceutical Company
06/03/2011 SC 13D KV PHARMACEUTICAL CO reports a 5% stake in K-V Pharmaceutical Company
11/29/2010 SC 13D KV PHARMACEUTICAL CO reports a 25% stake in As Made Applicable to the Issuer 12 C.F.R. Part 11 K-V Pharmaceutical Company
08/05/2009 SC 13D HERMELIN MARC S reports a 7.5% stake in K-V Pharmaceutical Company

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy